Customer concentration / non-repeat sell-in
Management disclosed that a new product sell-in to one customer in 2024 did not repeat in 2025, showing revenue sensitivity to individual orders.
- Scope
- Nutraceuticals revenue
- Materiality
- high
Synergy CHC Corp. is a U.S.-based consumer health company built around branded nutraceutical and ready-to-drink products. Its portfolio includes FOCUSfactor, a brain-health supplement line, and Flat Tummy, a lifestyle brand focused on weight-management and related nutritional products.
−27,4 %
66,8 %
−40,6 %
−12,8 %
1.22
0.76
| % | |
|---|---|
| Nutraceuticals | 88% Dietary supplements and related consumer health products sold under the company's brands. |
| Ready-to-Drink Beverages | 8% Packaged beverage extensions tied to the FOCUSfactor brand. |
| License Revenue | 4% Royalties or license fees from agreements to expand brands into selected territories. |
The company sells to consumers seeking brain-health, wellness, and weight-management products, primarily through...
Buy FOCUSfactor products for brain-health and general wellness use.
Buy Flat Tummy products for lifestyle and nutritional support.
Buy FOCUSfactor RTDs as a convenient extension of the brand.
Place and promote the products across consumer channels.
Use the brands in selected foreign territories under license agreements.
Synergy CHC Corp. is headquartered in the United States and appears to generate most of its business through U.S...
The company is focused on extending its existing brands into new markets and launching adjacent products, especially...
Beverage distribution can widen the brand's reach and add a new consumption occasion.
Product extensions help deepen shelf presence and reduce reliance on a single SKU set.
Licensing can scale brands internationally with lower direct operating complexity.
Acquisitions can add brands and broaden the consumer health portfolio.
The business depends on consumer demand, brand execution, and distribution access, so weak sell-through or delayed...
Management disclosed that a new product sell-in to one customer in 2024 did not repeat in 2025, showing revenue sensitivity to individual orders.
The company relies on notes payable and related financing, making interest burden and repayment timing important.
Packaging upgrades and shipment delays can move revenue across quarters and distort comparability.
Supplements and wellness products can face scrutiny over marketing claims, labeling, and product compliance.
Consumer health brands compete on shelf space, promotion, and brand awareness, which can affect sell-through.
: 29.4.2026